|
| |
- Bupisome*
- Ultra Long Local Anesthetic (up to 60 Hours)
- NasVax*
- special influenza vaccine for
nasal admission, high efficacy for elderly people, and children.
- CIL - Chemo Immuno Liposome
- a combination of chimotherapy drugs with liposomal cytokine to
substantially reduce cancer cells.
- HIV Inhibitor
- A Novel peptidomimetic small molecule that blocks CD4:GP120 interaction
& inhibits HIV-1 replication in cells.
- SIB
- A novel technology for converting peptides and proteins to small molecules.
- N.V.V
- Histone based non viral vector.
- OSD
- Oral Synchronous Drug Delivery System.
- Fore by Four
- A Noval Anti-cancer drug-combination.
- MMP
- Matrix Metalloproteinase (MMP), inhibitors with anti-metastasis and anti0restenosis activity.
- Target-In
- Chimeric (fusion) proteins that enables fully human proteins, fused on the DNA level, to
target specific diseased cell populations, and selectively eliminate them.
- Digopharm
- New Steroidal, Digitalis-Like, Sodium/Potassium ATPase Inhibitors.
- Protab*
- Rheumatodoid Arthritis- Vaccination Development Program.
- Melanoma Cancer
- Cancer Immunotherapy – A novel therapeutic approach.
- HSP70 peptide
- A Therapeutic Substance For Curing Type 1 Diabetics.
- Osteoporosis Therapy
- Heparanase Based Therapeutic In Osteoporosis; Alopecia; Organ & Bone Marrow Transplantation.
|
![[Company Logo Image]](images/bzb%20logo.jpg)
BZB Group
